In The Lancet in 1971, Julian Tudor Hart gave medicine one of its most important insights: the availability of medical care ...

With $500 million in funding and a reported $2.5 billion valuation, Flourish wants to reinvent AI by putting real neurons ...

Within the next couple of decades, the Key Largo woodrat could go extinct if the Burmese python population continues as is, a ...

Massive regional C2 footprint More than 1.3K C2 Servers Discovered in the Middle East Hunt.io said it identified more than ...

The new open-source atlas, generated by an AI tool called ESMFold2, vastly increases the known protein universe.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...